| Matthew Brandon, APRN | |
|
1414 Arkansas Blvd, Texarkana, AR 71854-1604 | |
| (870) 773-7246 | |
| Not Available |
| Full Name | Matthew Brandon |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 11 Years |
| Location | 1414 Arkansas Blvd, Texarkana, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194115691 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | A004194 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wadley Regional Medical Center | Texarkana, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ark-la-tex Health Center Pa | 7618862855 | 2 |
News Archive
Malignant hyperthermia (MH) is a life-threatening genetic muscle disorder, most commonly triggered in those at risk by certain types of drugs used during anesthesia. Heat stroke, on the other hand, most commonly occurs in individuals in response to physical exertion in hot/humid environments. While their common triggers may differ, the signs associated with MH and heat stroke are remarkably similar - uncontrolled muscle contractions, dangerous increases in body temperature, and muscle breakdown leading to the release of toxins in the blood which may cause cardiac arrhythmias and death. Immediate treatment for these conditions is crucial.
Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies - a multitude of painful blockages in small blood vessels that cause varying degrees of organ injury throughout the body. However, the two disorders have distinct biological mechanisms.
At the AIDS Vaccine 2010 conference last week in Atlanta, researchers emphasized the need for sustained funding for vaccine research and development in order to further progress toward an HIV vaccine, SciDev.Net reports.
The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).
› Verified 8 days ago
| Entity Name | Ark-la-tex Health Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649237165 PECOS PAC ID: 7618862855 Enrollment ID: O20040217001048 |
News Archive
Malignant hyperthermia (MH) is a life-threatening genetic muscle disorder, most commonly triggered in those at risk by certain types of drugs used during anesthesia. Heat stroke, on the other hand, most commonly occurs in individuals in response to physical exertion in hot/humid environments. While their common triggers may differ, the signs associated with MH and heat stroke are remarkably similar - uncontrolled muscle contractions, dangerous increases in body temperature, and muscle breakdown leading to the release of toxins in the blood which may cause cardiac arrhythmias and death. Immediate treatment for these conditions is crucial.
Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies - a multitude of painful blockages in small blood vessels that cause varying degrees of organ injury throughout the body. However, the two disorders have distinct biological mechanisms.
At the AIDS Vaccine 2010 conference last week in Atlanta, researchers emphasized the need for sustained funding for vaccine research and development in order to further progress toward an HIV vaccine, SciDev.Net reports.
The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Brandon, APRN 1414 Arkansas Blvd, Texarkana, AR 71854-1604 Ph: (870) 773-7246 | Matthew Brandon, APRN 1414 Arkansas Blvd, Texarkana, AR 71854-1604 Ph: (870) 773-7246 |
News Archive
Malignant hyperthermia (MH) is a life-threatening genetic muscle disorder, most commonly triggered in those at risk by certain types of drugs used during anesthesia. Heat stroke, on the other hand, most commonly occurs in individuals in response to physical exertion in hot/humid environments. While their common triggers may differ, the signs associated with MH and heat stroke are remarkably similar - uncontrolled muscle contractions, dangerous increases in body temperature, and muscle breakdown leading to the release of toxins in the blood which may cause cardiac arrhythmias and death. Immediate treatment for these conditions is crucial.
Two rare but potentially deadly blood-clotting diseases, namely thrombotic thrombocytopenic purpura, or TTP, and hemolytic uremic syndrome, or HUS, show similar pathologies - a multitude of painful blockages in small blood vessels that cause varying degrees of organ injury throughout the body. However, the two disorders have distinct biological mechanisms.
At the AIDS Vaccine 2010 conference last week in Atlanta, researchers emphasized the need for sustained funding for vaccine research and development in order to further progress toward an HIV vaccine, SciDev.Net reports.
The Centers for Disease Control and Prevention on Friday announced it anticipates 3.4 million doses of inhalable H1N1 vaccines will be available by the first week of October - the initial influx of 195 million doses purchased by the U.S. government, CNN reports. The vaccine is approved for healthy people between the ages of two and 49, but not for pregnant women (9/18).
› Verified 8 days ago
Tommy Caldwell, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1205 E 35th St, Texarkana, AR 71854 Phone: 903-614-5355 Fax: 903-614-5399 | |
Deborah L Porchia, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 300 E 6th St, Texarkana, AR 71854 Phone: 870-779-6000 Fax: 870-779-6125 | |
Mrs. Crystal Marie Stanberry, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1205 E 35th St, Texarkana, AR 71854 Phone: 903-735-5355 | |
Ms. Gracie Mae Adkisson, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2301 Pecan St, Texarkana, AR 71854 Phone: 903-278-5906 | |
Belinda K Doss, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 401 East St, Texarkana, AR 71854 Phone: 870-773-2177 Fax: 870-773-2758 | |
Porscha Nicole Branch, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1205 E 35th St, Texarkana, AR 71854 Phone: 870-216-0050 Fax: 870-216-0096 | |
Mrs. Martega Marie Walton, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1307 Trinity Blvd, Texarkana, AR 71854 Phone: 870-773-6467 Fax: 870-216-0061 |